Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPa expression

K.J. Yong, D.S. Basseres, R.S. Welner, W.C. Zhang, H. Yang, B. Yan, M. Alberich-Jorda, J. Zhang, L.L. De Figueiredo-Pontes, C. Battelli, C.J. Hetherington, M. Ye, H. Zhang, G. Maroni, K. O'Brien, M.C. Magli, A.C. Borczuk, L. Varticovski, O. Kocher, P. ZhangY.C. Moon, N. Sydorenko, L. Cao, T.W. Davis, B.M. Thakkar, Roland A. Soo, A. Iwama, B. Lim, B. Halmos, D. Neuberg, D.G. Tenen, E. Levantini

    Research output: Contribution to journalArticlepeer-review

    47 Citations (Web of Science)

    Fingerprint

    Dive into the research topics of 'Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPa expression'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science

    Biochemistry, Genetics and Molecular Biology